AGP Picks
View all

Health Channel of Togo
Provided by AGP

Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 11, 2026

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
May 11, 2026

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

Indeterminate GlobeNewswire
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
May 11, 2026

BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026

Indeterminate GlobeNewswire
CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline
May 11, 2026

CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline

Indeterminate GlobeNewswire
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
May 11, 2026

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Indeterminate GlobeNewswire
Cellectis publie ses résultats financiers du premier trimestre 2026
May 11, 2026

Cellectis publie ses résultats financiers du premier trimestre 2026

Indeterminate GlobeNewswire
FDA Advances Drug Repurposing to Address Unmet Medical Needs
May 11, 2026

FDA Advances Drug Repurposing to Address Unmet Medical Needs

Indeterminate GlobeNewswire
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026

CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC

Indeterminate GlobeNewswire
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 11, 2026

Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
May 11, 2026

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
May 11, 2026

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

Indeterminate GlobeNewswire
Oculis Reports Q1 2026 Financial Results and Provides Company Update
May 11, 2026

Oculis Reports Q1 2026 Financial Results and Provides Company Update

Indeterminate GlobeNewswire
Abivax Announces Results of its May 11, 2026 Annual General Meeting
May 11, 2026

Abivax Announces Results of its May 11, 2026 Annual General Meeting

Indeterminate GlobeNewswire
CVRx Reports First Quarter 2026 Financial and Operating Results
May 11, 2026

CVRx Reports First Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire
Ceribell Reports First Quarter 2026 Financial Results
May 11, 2026

Ceribell Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 11, 2026

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
May 11, 2026

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 11, 2026

LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 
May 11, 2026

Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 

Indeterminate GlobeNewswire
Health Catalyst Reports First Quarter 2026 Results
May 11, 2026

Health Catalyst Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Channel of Togo

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.